EPISEEK™ Multi-Cancer Early Detection Test + Evaluation

The EPISEEK™ Tests Detects All Major Cancer Types

Price Includes 60 minute visit with our Medical Providers

Take control of your health with EPISEEK™ — a cutting-edge, blood-based test designed to detect early cancer signals. With its ability to identify DNA shed by tumors (ctDNA), EPISEEK™ offers a highly accurate, minimally invasive alternative to traditional cancer screenings.

This test analyzes epigenomic modifications using advanced technology to detect cancer-specific DNA markers. It can identify over 14 major cancer types, even before symptoms appear. Whether for general health monitoring or as part of a high-risk screening, EPISEEK™ empowers you to catch cancer earlier, when it’s most treatable.

Key Features

• Detects cancer-related DNA markers with 99% specificity.
• Comprehensive coverage for 14+ cancer types, including brain, breast, prostate, lung, and more.
• Suitable for adults aged 45+ with elevated cancer risk.
• Non-invasive blood test, no need for tissue biopsy or imaging.
• Highly accurate with a sensitivity rate of up to 73% for Stage III cancers.
• Results available quickly for peace of mind.

Cancer Types Detected

• Brain
• Lung & Bronchus
• Breast
• Colon & Rectum
• Prostate
• Bladder
• Kidney
• Pancreas
• Uterine & Cervical
• Lymphoma
• Myeloma & Leukemia
• Thyroid
• Oral
• Liver
• Esophagus
• Ovarian

How It Works

1. Simple Blood Draw: A quick, non-invasive blood test.
2. DNA Analysis: The test identifies circulating tumor DNA (ctDNA) in your blood.
3. Early Detection: Epigenomic modifications are analyzed to detect cancer at its earliest stages.

Why Choose EPISEEK™?

• Early Detection: Cancer is most treatable in its earliest stages, and EPISEEK™ can catch cancers that may not be visible on imaging.
• Cost-Effective: A more affordable alternative to traditional biopsies and imaging scans.
• Convenience: Minimal inconvenience with a blood draw, no need for tissue biopsy.
• Accuracy You Can Trust: High specificity and sensitivity, particularly in hard-to-detect cancers.

Important Notes

• EPISEEK™ is intended for use by adults aged 45 and older or those at higher risk of cancer.
• This test should complement routine cancer screenings and not replace them.
• Pregnant individuals, those under 21, or those undergoing active cancer treatment should not use this test.
• A negative result does not completely rule out cancer; further testing may be required.

After your purchase,  you will be contacted to schedule a blood draw in our office